Familial Haploidentical (FHI) T-cell Depleted (TCD) With T-cell Addback Stem Cell Transplantation for Patients With High-Risk Sickle Cell Disease (SCD)

Authors

J Talano
Cori M. Abikoff, New York Medical CollegeFollow
M Walters
T Moore
S Parsons
Allen Dozor, New York Medical CollegeFollow
Deborah Friedman, New York Medical CollegeFollow
Qiuhu Shi, New York Medical CollegeFollow
S Braniecki
B Grossman
R Weinberg
E Morris
P Brand
S Fabricatore
J AyelloFollow
M Semidei-Pomales
L Baxter-Lowe
Mitchell Cairo, New York Medical CollegeFollow

Document Type

Abstract

Publication Date

3-1-2017

DOI

10.1016/j.bbmt.2016.12.480

Journal Title

Biology of Blood and Marrow Transplantation

Department

Pediatrics

Second Department

Environmental Health Science

Third Department

Epidemiology and Community Health

Recommended Citation

Talano, J., Abikoff, C. M., Walters, M., Moore, T., Parsons, S., Dozor, A., Friedman, D., Shi, Q., Braniecki, S., Grossman, B., Weinberg, R., Morris, E., Brand, P., Fabricatore, S., Ayello, J., Semidei-Pomales, M., Baxter-Lowe, L., & Cairo, M. (2017). Familial Haploidentical (FHI) T-cell Depleted (TCD) With T-cell Addback Stem Cell Transplantation for Patients With High-Risk Sickle Cell Disease (SCD). Biology of Blood and Marrow Transplantation, 23 (3 Suppl.), S246-S247. https://doi.org/10.1016/j.bbmt.2016.12.480